Inventor · disambiguated record
Mark David Brennan
Also filed as: BRENNAN MARK · BRENNAN MARK D · BRENNAN MARK DAVID
16 granted patents·13 pending applications·22 citations·filing 2005–2015
89Inventor score
Files withSUREGENE LLC12BRENNAN MARK DAVID10RAMSEY TIMOTHY L3UNIV LOUISVILLE RES FOUND3CLINICAL REFERENCE LABORATORY INC1
Top patents by PatentIndex Score
29 records- 0189US7790396B1Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotypeSUREGENE LLC·Filed 2009·Granted Sep 7, 2010·13 cites·7 claims
- 0283US8114600B2Genetic markers of schizophrenia endophenotypesBRENNAN MARK DAVID·Filed 2009·Granted Feb 14, 2012·2 cites·11 claims
- 0377US7892735B2Genetic markers of schizophrenia spectrum disorders in the sulfotransferase 4a (sult4a) geneUNIV LOUISVILLE RES FOUND·Filed 2005·Granted Feb 22, 2011·3 cites·22 claims
- 0475US8129117B2Genetic markers for assessing risk of developing bipolar disorderBRENNAN MARK DAVID·Filed 2009·Granted Mar 6, 2012·0 cites·17 claims
- 0575US7932042B1Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signatureSUREGENE LLC·Filed 2010·Granted Apr 26, 2011·2 cites·6 claims
- 0674US8067160B2Genetic markers of schizophreniaBRENNAN MARK DAVID·Filed 2007·Granted Nov 29, 2011·1 cites·9 claims
- 0773US8586308B2Genetic markers of mental illnessBRENNAN MARK DAVID·Filed 2009·Granted Nov 19, 2013·0 cites·30 claims
- 0872US8263337B2Genetic markers of schizophreniaBRENNAN MARK DAVID·Filed 2011·Granted Sep 11, 2012·1 cites·18 claims
- 0971US2014350000A1Genetic Markers for Optimizing Treatment for SchizophreniaSUREGENE LLC·Filed 2014·Application pending·0 cites
- 1066US2010279423A1Genetic markers of mental illnessBRENNAN MARK DAVID·Filed 2009·Application pending·0 cites
- 1164US9040241B2Genetic markers of mental illnessSUREGENE LLC·Filed 2013·Granted May 26, 2015·0 cites·30 claims
- 1264US2012100637A1Genetic markers of schizophrenia endophenotypesBRENNAN MARK DAVID·Filed 2012·Application pending·0 cites
- 1364US2012129171A1Genetic Markers for Assessing Risk of Developing Bipolar DisorderBRENNAN MARK DAVID·Filed 2012·Application pending·0 cites
- 1463US7985551B2Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotypeSUREGENE LLC·Filed 2009·Granted Jul 26, 2011·0 cites·8 claims
- 1563US2015167086A1Genetic markers of mental illnessSUREGENE LLC·Filed 2014·Application pending·0 cites
- 1660US9738934B2Genetic markers of mental illnessCLINICAL REFERENCE LABORATORY INC·Filed 2015·Granted Aug 22, 2017·0 cites·24 claims
- 1760US8460868B2Genetic markers for schizophrenia and bipolar disorderBRENNAN MARK DAVID·Filed 2008·Granted Jun 11, 2013·0 cites·12 claims
- 1858US2016168637A1Genetic markers of mental illnessSUREGENE LLC·Filed 2015·Application pending·0 cites
- 1956US7972793B2Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotypeSUREGENE LLC·Filed 2010·Granted Jul 5, 2011·0 cites·8 claims
- 2055US8318429B2Genetic markers of schizophreniaBRENNAN MARK DAVID·Filed 2011·Granted Nov 27, 2012·0 cites·18 claims
- 2153US2016122821A1Genetic markers of antipsychotic responseSUREGENE LLC·Filed 2014·Application pending·0 cites
- 2252US2012277211A1Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotypeRAMSEY TIMOTHY L·Filed 2010·Application pending·0 cites
- 2351US2011143341A1Microsatellite Markers of SchizophreniaUNIV LOUISVILLE RES FOUND·Filed 2011·Application pending·0 cites
- 2450US2016273042A1Genetic markers of antipsychotic responseSUREGENE LLC·Filed 2014·Application pending·0 cites
- 2546US2012094854A1Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor gene signatureRAMSEY TIMOTHY L·Filed 2011·Application pending·0 cites
- 2644US7951542B2Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotypeSUREGENE LLC·Filed 2010·Granted May 31, 2011·0 cites·17 claims
- 2742US2011117215A1Microsatellite Markers of SchizophreniaUNIV LOUISVILLE RES FOUND·Filed 2011·Application pending·0 cites
- 2837US2013090329A1Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic SignatureRAMSEY TIMOTHY L·Filed 2011·Application pending·0 cites
- 2936US7951543B2Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotypeSUREGENE LLC·Filed 2010·Granted May 31, 2011·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Mark David Brennan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →